Eikon Therapeutics, Inc. (EIKN)
$11.16-2.02%Close
BUY
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $33M
- Avg volume
- 370.9K
- Beta
- 0.86
- P/E (TTM)
- -2.55
- Short % float
- 165.86%
- Days to cover
- 20.0
- SI change
- +5.3%
- 1W
- +6.59%
- 1M
- +25.39%
- 3M
- +2.29%
- YTD
- -25.60%
- vs SPY 1W
- +7.78%
- vs SPY 1M
- +22.07%
- vs SPY 3M
- -0.10%
- vs SPY YTD
- -37.35%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- KLRASELLKailera Therapeutics, Inc.Q -44$16.54-3.67%
- ABVXSELLAbivax S.A.BEARQ 61$116.15+1.04%
- ERASSELLErasca, Inc.RECOVERYQ 6$17.60-0.17%
- MLYSSELLMineralys Therapeutics, Inc.RECOVERYQ 21$25.27-1.48%
- RVMDBUYRevolution Medicines, Inc.BULLQ 31$211.58+1.01%
- SVRASELLSavara Inc.RECOVERYQ 12$5.56-0.54%
- ANIXBUYAnixa Biosciences, Inc.RECOVERYQ 6$3.62-2.43%
- ANROBUYAlto Neuroscience, Inc.BULLQ 27$36.25+5.75%
- CTNMBUYContineum Therapeutics, Inc. Class A Common StockRECOVERYQ 13$16.63-3.26%
- SMMTSELLSummit Therapeutics Inc.CRISISQ 16$12.73-3.27%
- FBIOSELLFortress Biotech, Inc.RECOVERYQ -9$2.93+2.09%
- SGRYSELLSurgery Partners, Inc.CRISISQ 7$13.95-3.93%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 15
- GROWTH
- 41
- GARP
- 8
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC90.4%
REV YoY-
ROE150.7%
EPS YoY-
ROA-32.2%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-2.55
P/E FWD-
SECTOR PE22.62
INDUSTRY PE17.13
P/B1.37
P/FCF-
EV/EBITDA-3.15
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E54.07
ALTMAN Z-
CURR RATIO9.89
ND/EBITDA-
BETA0.86
